Dingdang Health Buys Back 0.17 Million Shares, Lifting Treasury Stock to 5.20 Million

Bulletin Express09-24

On 24 September 2026, Dingdang Health Technology Group Ltd. executed an on-market repurchase of 170,500 ordinary shares, equal to 0.0138% of the company’s issued share capital (excluding treasury shares) as of the previous day. The shares were acquired on the Hong Kong Stock Exchange at prices ranging between HKD 0.78 and HKD 0.80, with a volume-weighted average cost of HKD 0.793 per share, for a total consideration of HKD 0.14 million.

Following the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) fell to 1.24 billion, while treasury shares rose to 5.20 million. The buyback was conducted under the repurchase mandate approved on 23 June 2026, which authorises the purchase of up to 124.32 million shares. Including the latest trade, Dingdang Health has repurchased 8.06 million shares under this mandate, representing 0.65% of the issued share base at the mandate date.

All 170,500 repurchased shares have been retained as treasury shares; none have been cancelled. In accordance with Hong Kong listing rules, Dingdang Health is subject to a moratorium on issuing new shares or disposing of treasury shares until 24 October 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1106473807?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-24 18:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1106473807","market":"hk","top_or_hot":-1,"title":"Dingdang Health Buys Back 0.17 Million Shares, Lifting Treasury Stock to 5.20 Million","media":"Bulletin Express","content":"<p>On 24 September 2026, Dingdang Health Technology Group Ltd. executed an on-market repurchase of 170,500 ordinary shares, equal to 0.0138% of the company’s issued share capital (excluding treasury shares) as of the previous day. The shares were acquired on the Hong Kong Stock Exchange at prices ranging between HKD 0.78 and HKD 0.80, with a volume-weighted average cost of HKD 0.793 per share, for a total consideration of HKD 0.14 million.</p>\n<p>Following the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) fell to 1.24 billion, while treasury shares rose to 5.20 million. The buyback was conducted under the repurchase mandate approved on 23 June 2026, which authorises the purchase of up to 124.32 million shares. Including the latest trade, Dingdang Health has repurchased 8.06 million shares under this mandate, representing 0.65% of the issued share base at the mandate date.</p>\n<p>All 170,500 repurchased shares have been retained as treasury shares; none have been cancelled. In accordance with Hong Kong listing rules, Dingdang Health is subject to a moratorium on issuing new shares or disposing of treasury shares until 24 October 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health Buys Back 0.17 Million Shares, Lifting Treasury Stock to 5.20 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health Buys Back 0.17 Million Shares, Lifting Treasury Stock to 5.20 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-24 18:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 24 September 2026, Dingdang Health Technology Group Ltd. executed an on-market repurchase of 170,500 ordinary shares, equal to 0.0138% of the company’s issued share capital (excluding treasury shares) as of the previous day. The shares were acquired on the Hong Kong Stock Exchange at prices ranging between HKD 0.78 and HKD 0.80, with a volume-weighted average cost of HKD 0.793 per share, for a total consideration of HKD 0.14 million.</p>\n<p>Following the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) fell to 1.24 billion, while treasury shares rose to 5.20 million. The buyback was conducted under the repurchase mandate approved on 23 June 2026, which authorises the purchase of up to 124.32 million shares. Including the latest trade, Dingdang Health has repurchased 8.06 million shares under this mandate, representing 0.65% of the issued share base at the mandate date.</p>\n<p>All 170,500 repurchased shares have been retained as treasury shares; none have been cancelled. In accordance with Hong Kong listing rules, Dingdang Health is subject to a moratorium on issuing new shares or disposing of treasury shares until 24 October 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1106473807","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1106473807","pubTimestamp":1790244277,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 24 September 2026, Dingdang Health Technology Group Ltd. executed an on-market repurchase of 170,500 ordinary shares, equal to 0.0138% of the company’s issued share capital (excluding treasury...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康回购17万股，库存股增至520万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"On 24 September 2026, Dingdang Health Technology Group Ltd. executed an on-market repurchase of 170,500 ordinary shares, equal to 0.0138% of the company’s issued share capital (excluding treasury shares) as of the previous day. The shares were acquired on the Hong Kong Stock Exchange at prices ranging between HKD 0.78 and HKD 0.80, with a volume-weighted average cost of HKD 0.793 per share, for a total consideration of HKD 0.14 million.\nFollowing the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) fell to 1.24 billion, while treasury shares rose to 5.20 million. The buyback was conducted under the repurchase mandate approved on 23 June 2026, which authorises the purchase of up to 124.32 million shares. Including the latest trade, Dingdang Health has repurchased 8.06 million shares under this mandate, representing 0.65% of the issued share base at the mandate date.\nAll 170,500 repurchased shares have been retained as treasury shares; none have been cancelled. In accordance with Hong Kong listing rules, Dingdang Health is subject to a moratorium on issuing new shares or disposing of treasury shares until 24 October 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1106473807","isCrawlerRequest":true}